655 related articles for article (PubMed ID: 29307848)
21. A prospective nationwide study of drug-induced liver injury in Korea.
Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
[TBL] [Abstract][Full Text] [Related]
22. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced liver injury.
Katarey D; Verma S
Clin Med (Lond); 2016 Dec; 16(Suppl 6):s104-s109. PubMed ID: 27956449
[TBL] [Abstract][Full Text] [Related]
24. Presentation of drug-induced liver injury in Singapore.
Wai CT
Singapore Med J; 2006 Feb; 47(2):116-20. PubMed ID: 16435052
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics of Patients with Drug-induced Liver Injury.
Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
[TBL] [Abstract][Full Text] [Related]
26. Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
Stolz A; Navarro V; Hayashi PH; Fontana RJ; Barnhart HX; Gu J; Chalasani NP; Vega MM; Bonkovsky HL; Seeff LB; Serrano J; Avula B; Khan IA; Cirulli ET; Kleiner DE; Hoofnagle JH;
Aliment Pharmacol Ther; 2019 May; 49(9):1195-1204. PubMed ID: 30934130
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
[TBL] [Abstract][Full Text] [Related]
28. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
29. The Diagnosis and Manifestations of Liver Injury Secondary to Off-Label Androgenic Anabolic Steroid Use.
Cabb E; Baltar S; Powers DW; Mohan K; Martinez A; Pitts E
Case Rep Gastroenterol; 2016; 10(2):499-505. PubMed ID: 27721739
[TBL] [Abstract][Full Text] [Related]
30. Severe liver injury due to herbal and dietary supplements and the role of liver transplantation.
Grewal P; Ahmad J
World J Gastroenterol; 2019 Dec; 25(46):6704-6712. PubMed ID: 31857773
[TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity associated with dietary supplements containing anabolic steroids.
Kafrouni MI; Anders RA; Verma S
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):809-12. PubMed ID: 17509944
[TBL] [Abstract][Full Text] [Related]
32. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Navarro VJ; Barnhart H; Bonkovsky HL; Davern T; Fontana RJ; Grant L; Reddy KR; Seeff LB; Serrano J; Sherker AH; Stolz A; Talwalkar J; Vega M; Vuppalanchi R
Hepatology; 2014 Oct; 60(4):1399-408. PubMed ID: 25043597
[TBL] [Abstract][Full Text] [Related]
33. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
[TBL] [Abstract][Full Text] [Related]
35. Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.
Zhu Y; Li YG; Wang JB; Liu SH; Wang LF; Zhao YL; Bai YF; Wang ZX; Li JY; Xiao XH
Gut Liver; 2015 Jul; 9(4):525-33. PubMed ID: 25717050
[TBL] [Abstract][Full Text] [Related]
36. The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.
Chen SS; Yu KK; Huang C; Li N; Zheng JM; Bao SX; Chen MQ; Zhang WH
Medicine (Baltimore); 2016 Aug; 95(34):e4683. PubMed ID: 27559976
[TBL] [Abstract][Full Text] [Related]
37. Drug-Induced Liver Injury: Pattern Recognition and Future Directions.
Haque T; Sasatomi E; Hayashi PH
Gut Liver; 2016 Jan; 10(1):27-36. PubMed ID: 26696029
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced hepatocellular injury due to herbal supplement ashwagandha.
Ireland PJ; Hardy T; Burt AD; Donnelly MC
J R Coll Physicians Edinb; 2021 Dec; 51(4):363-365. PubMed ID: 34882134
[TBL] [Abstract][Full Text] [Related]
39. Amoxicillin-Clavulanate-Induced Liver Injury.
deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and pathological analysis of 100 cases of drug-induced liver injury].
Zhou GD; Zhao JM; Zhang LX; Sun YL; Pan D; Yang JF; Zhao YL
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):212-5. PubMed ID: 17407714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
